RxDoctor Payments DataLook up a doctor →

Mehrullah Khan, MD

Neurology · Hagerstown, MDNPI 1578564761

Payments from drug & device makers

$71,951in general payments, 2019–2025

Across 1,008 payments — averaging $71.38 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novartis$56K
  • AbbVie$2K
  • Lilly USA, LLC$1K
  • AstraZeneca$1K
  • Amgen$843
  • UCB, Inc.$826
  • plus $10K from 50 others

General payments by program year

19
20
21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Novartis119$55,828
AbbVie(2 entities)138$2,140
Lilly USA, LLC68$1,309
AstraZeneca(2 entities)48$1,100
Amgen(2 entities)54$843
UCB, Inc.37$826
Biogen36$686
Teva Pharmaceuticals USA, Inc.34$629
Eisai Inc.34$621
EMD Serono, Inc.23$545
Supernus Pharmaceuticals, Inc.25$485
Lundbeck LLC22$467
Neurelis, Inc.27$466
Kyowa Kirin, Inc.23$466
Sunovion Pharmaceuticals Inc.27$426
Pfizer23$365
Biohaven Pharmaceutical Holding Company Ltd.43$338
Bristol Myers Squibb18$313
Amneal Pharmaceuticals LLC15$307
Genentech USA, Inc.13$286
Argenx US, Inc.9$231
Adamas Pharmaceuticals, Inc.16$230
Sanofi11$228
Tanabe Pharma America, Inc.11$226
Neurocrine Biosciences, Inc.9$201
Acorda Therapeutics, Inc11$193
Alnylam Pharmaceuticals Inc.8$185
ANI Pharmaceuticals, Inc.7$177
MDD US Operations, LLC6$169
Upsher-smith Laboratories LLC9$157
TG Therapeutics, Inc.7$143
Johnson & Johnson6$127
Greenwich Biosciences, Inc.7$121
Acadia Pharmaceuticals Inc9$121
Biohaven Pharmaceuticals, Inc.7$120
Avanir Pharmaceuticals, Inc.4$93
Mallinckrodt Hospital Products Inc.5$86
Livanova USA, Inc.4$63
E.r. Squibb & Sons, L.L.C.4$61
Grifols USA, LLC4$61
Sumitomo Pharma America, Inc.3$59
Promius Pharma LLC3$53
Currax Pharmaceuticals LLC4$53
SK Life Science, Inc.2$47
Avion Pharmaceuticals2$41
Mallinckrodt Enterprises LLC2$34
Life Molecular Imaging Ltd1$33
Medtronic2$30
GRT US Holding, Inc.1$25
Scilex Pharmaceuticals Inc.1$22
Abbott1$21
Catalyst Pharmaceuticals, Inc.1$21
Corium, LLC1$20
Cala Health, Inc.1$20
Biotronik NRO, Inc.1$19
Jazz Pharmaceuticals Inc.1$15

How this compares

$71,951 in reported general payments places this provider in the 85th percentile of 442 neurology providers in Maryland.

See all neurology providers in Maryland →

Medicare billing

Part B allowed, 2024
$204,215
Medicare patients
517
Services billed
6,150

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other neurology in Hagerstown

See the full list for Maryland →

Where these figures come from

Is this you, or does something look wrong? →